X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs ALEMBIC LTD - Comparison Results

BIOCON     Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON ALEMBIC LTD BIOCON /
ALEMBIC LTD
 
P/E (TTM) x 39.1 53.1 73.8% View Chart
P/BV x 6.2 2.1 290.8% View Chart
Dividend Yield % 0.2 0.5 39.0%  

Financials

 BIOCON    ALEMBIC LTD
EQUITY SHARE DATA
    BIOCON
Mar-18
ALEMBIC LTD
Mar-18
BIOCON /
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs1,18872 1,650.0%   
Low Rs30534 899.7%   
Sales per share (Unadj.) Rs68.74.7 1,462.0%  
Earnings per share (Unadj.) Rs7.66.1 123.7%  
Cash flow per share (Unadj.) Rs14.06.2 223.7%  
Dividends per share (Unadj.) Rs1.000.20 500.0%  
Dividend yield (eoy) %0.10.4 35.5%  
Book value per share (Unadj.) Rs86.340.7 212.4%  
Shares outstanding (eoy) m600.00267.03 224.7%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x10.911.3 96.4%   
Avg P/E ratio x98.98.7 1,139.5%  
P/CF ratio (eoy) x53.48.5 630.2%  
Price / Book Value ratio x8.61.3 663.9%  
Dividend payout %13.23.3 404.1%   
Avg Mkt Cap Rs m447,90014,139 3,167.8%   
No. of employees `0006.1NA-   
Total wages/salary Rs m9,311207 4,489.4%   
Avg. sales/employee Rs Th6,705.8NM-  
Avg. wages/employee Rs Th1,514.2NM-  
Avg. net profit/employee Rs Th736.9NM-  
INCOME DATA
Net Sales Rs m41,2341,255 3,285.1%  
Other income Rs m2,062370 557.0%   
Total revenues Rs m43,2961,625 2,663.7%   
Gross profit Rs m8,291111 7,462.6%  
Depreciation Rs m3,85138 10,187.8%   
Interest Rs m6152 36,176.5%   
Profit before tax Rs m5,887442 1,332.5%   
Minority Interest Rs m2130-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,56924 6,551.1%   
Profit after tax Rs m4,5311,630 278.0%  
Gross profit margin %20.18.9 227.2%  
Effective tax rate %26.75.4 491.6%   
Net profit margin %11.0129.8 8.5%  
BALANCE SHEET DATA
Current assets Rs m41,4861,867 2,221.9%   
Current liabilities Rs m21,413591 3,622.0%   
Net working cap to sales %48.7101.6 47.9%  
Current ratio x1.93.2 61.3%  
Inventory Days Days6494 67.9%  
Debtors Days Days9474 128.1%  
Net fixed assets Rs m50,6611,791 2,828.8%   
Share capital Rs m3,000534 561.7%   
"Free" reserves Rs m48,80810,324 472.8%   
Net worth Rs m51,80810,858 477.2%   
Long term debt Rs m17,89841 43,441.7%   
Total assets Rs m99,89711,591 861.9%  
Interest coverage x10.6260.9 4.1%   
Debt to equity ratio x0.30 9,104.3%  
Sales to assets ratio x0.40.1 381.1%   
Return on assets %5.214.1 36.6%  
Return on equity %8.715.0 58.3%  
Return on capital %9.615.2 63.4%  
Exports to sales %01.5 0.0%   
Imports to sales %021.0 0.0%   
Exports (fob) Rs mNA19 0.0%   
Imports (cif) Rs mNA263 0.0%   
Fx inflow Rs m12,05819 62,154.6%   
Fx outflow Rs m7,348264 2,785.2%   
Net fx Rs m4,710-244 -1,927.0%   
CASH FLOW
From Operations Rs m6,621236 2,807.9%  
From Investments Rs m-6,840-224 3,053.6%  
From Financial Activity Rs m-2,397-27 9,011.3%  
Net Cashflow Rs m-2,612-15 17,648.6%  

Share Holding

Indian Promoters % 40.4 64.0 63.1%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 0.2 4,200.0%  
FIIs % 10.7 9.7 110.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 26.1 76.2%  
Shareholders   109,995 54,701 201.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SANOFI INDIA  ABBOTT INDIA  PLETHICO PHARMA  CIPLA  TORRENT PHARMA  

Compare BIOCON With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Modi's Victory Creates Sensex History; Ache Din Ahead?(Podcast)

Throughout the week, one slogan that took over the market and country as a whole was, Ab ki baar phir Modi Sarkar.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


May 24, 2019 (Close)

TRACK BIOCON

BIOCON - PLETHICO PHARMA COMPARISON

COMPARE BIOCON WITH

MARKET STATS